A use of a neural network to evaluate contrast enhancement curves in breast magnetic resonance images.
For the diagnosis of breast cancer using magnetic resonance imaging (MRI), one of the most important parameters is the analysis of contrast enhancement. A three-dimensional MR sequence is applied before and five times after bolus injection of paramagnetic contrast medium (Gd-DTPA). The dynamics of absorption are described by a time/intensity enhancement curve, which reports the mean intensity of the MR signal in a small region of interest (ROI) for about 8 minutes after contrast injection. The aim of our study was to use an artificial neural network to automatically classify the enhancement curves as "benign" or "malignant." We used a classic feed-forward back-propagation neural network, with three layers: five input nodes, two hidden nodes, and one output node. The network has been trained with 26 pathologic curves (10 invasive carcinoma [K], two carcinoma-in-situ [DCIS], and 14 benign lesion [B]). The trained network has been tested with 58 curves (36 K, one DCIS, 21 B). The network was able to correctly identify the test curves with a sensitivity of 76% and a specificity of 90%. For comparison, the same set of curves was analyzed separately by two radiologists (a breast MR expert and a resident radiologist). The first correctly interpreted the curves with a sensitivity of 76% and a specificity of 90%, while the second scored 59% for sensitivity and 90% for specificity. These results demonstrate that a trained neural network recognizes the pathologic curves at least as well as an expert radiologist. This algorithm can help the radiologist attain rapid and affordable screening of a large number of ROIs. A complete automatic computer-aided diagnosis support system should find a number of potentially interesting ROIs and automatically analyze the enhancement curves for each ROI by neural networks, reporting to the radiologist only the potentially pathologic ROIs for a more accurate, manual, repeated evaluation.
Vergnaghi
D
D
Department of Images for Diagnosis and Therapy, National Cancer Institute, Milan, Italy. Vergnaghi@istitutotumori.mi.it
Monti
A
A
Setti
E
E
Musumeci
R
R
D001940:Breast / Q000473:pathology*; D001943:Breast Neoplasms / Q000175:diagnosis*; D003287:Contrast Media; D005260:Female; D019786:Gadolinium DTPA; D006801:Humans; D008279:Magnetic Resonance Imaging; D016571:Neural Networks, Computer; D012680:Sensitivity and Specificity
D003287:Contrast Media; D019786:Gadolinium DTPA